Reauthorization of the Rare Pediatric Disease Priority Review Voucher Program
HON. MICHAEL T. McCAUL of Texas in the House of Representatives
Thursday, July 14, 2016
This program is a crucial incentive--in addition to the Orphan Drug Act--for drug manufacturers to invest significantly in developing therapies for rare pediatric diseases, including pediatric cancers and lysosomal storage disorders.
